Table 5 Annual respiratory-related resource utilization and direct costs
From: Healthcare burden of pulmonary hypertension owing to lung disease and/or hypoxia
Type | Group 3 PH | Controls | Unadjusted DID (95% CI) | Adjusted DID (95% CI) | P value | ||||
|---|---|---|---|---|---|---|---|---|---|
Baseline | Follow-up | Difference | Baseline | Follow-up | Difference | ||||
Respiratory-related utilization, n | |||||||||
Inpatient admissions | 1.4 (4.7) | 2.2 (6.0) | 0.8 (5.9) | 0.8 (3.0) | 0.8 (3.1) | −0.1 (2.5) | 0.9 (0.6-1.2) | 1.1 (0.8–1.4) | <.0001 |
Outpatient visits | 4.0 (8.0) | 5.3 (10.1) | 1.3 (8.0) | 1.6 (4.2) | 1.6 (4.5) | −0.04 (3.9) | 1.4 (1.0–1.8) | 1.3 (0.9–1.7) | <.0001 |
Physician office visits | 2.2 (3.6) | 2.6 (3.7) | 0.4 (3.5) | 1.5 (2.3) | 1.3 (2.4) | −0.2 (2.3) | 0.5 (0.4–0.7) | 0.7 (0.5–0.9) | <.0001 |
ED visits | 0.1 (0.5) | 0.2 (0.6) | 0.0 (0.6) | 0.1 (0.3) | 0.1 (0.4) | 0.0 (0.4) | 0.01 (−0.02–0.04) | 0.02 (−0.01–0.05) | 0.28 |
Respiratory-related costs, US$ | |||||||||
Total | 3405 (16,246) | 5089 (36,980) | 1684 (38,082) | 862 (2736) | 587 (2541) | −275 (3068) | 1960 (376–3544) | 1856 (177–3534) | 0.0303 |
Inpatient | 2181 (15,301) | 3652 (36,218) | 1472 (37,958) | 316 (2112) | 158 (1327) | −159 (2324) | 1630 (54–3207) | 1511 (−160–3182) | 0.0764 |
Outpatient | 733 (2566) | 981 (2909) | 248 (3138) | 240 (1194) | 176 (1762) | −64 (1627) | 312 (165–458) | 319 (164–474) | <0.0001 |
Physician office | 156 (454) | 148 (370) | −8 (433) | 67 (235) | 39 (166) | −28 (246) | 19 (−1–40.0) | 26 (4–48) | 0.0191 |
ED visit | 70 (796) | 59 (526) | −11 (715) | 12 (112) | 11 (114) | −1 (139) | −11 (−41–20) | −2 (−34–30) | 0.8875 |